Rexahn Pharmaceuticals, Inc. (REXN)

[Valensio]

It was a voluntary r/s, I don't think a lot of retail investors know that. I think a lot of people think it was the usual reason most bio's are forced to do it, to get compliance with a $1 share price requirement, which rnn isn't required to do. This was solely by choice only to get the pps higher to a level where bigger institutions can invest in rnn now since many are forbidden to invest in a stocks below $5/share & some $1/share. It wouldn't surprise me if they had a partnership in works or a bigger pharma waiting to buy in once this new higher post r/s share price takes effect.